LeafNLP Demos
Back to explore

Report #2888729

Received Mar 12, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
ID
Recovered
Unknown
Vaccinated
Feb 20, 2026
Onset
Feb 20, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNK——
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNK——

Symptoms (3)

Extra dose administeredNo adverse eventWrong product administered

Symptom narrative

No additional AE reported; She states she inadvertently administered PROQUAD and VARIVAX at the same time today (2/20/2026) instead of MMR II and VARIVAX to a 42-year-old Male; She states she inadvertently administered PROQUAD and VARIVAX at the same time today (2/20/2026) instead of MMR II and VARIVAX to a 42-year-old Male; She states she inadvertently administered PROQUAD and VARIVAX at the same time today (2/20/2026) instead of MMR II and VARIVAX to a 42-year-old Male; This spontaneous report was received from a Medical Assistant and refers to a 42-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-Feb-2026, the patient was vaccinated inadvertently with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) solution for injection, administered as prophylaxis (refused to answer/refused to answer) (lot # and expiration date were not reported); and with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) solution for injection, administered as prophylaxis (refused to answer/refused to answer) (lot # and expiration date were not reported), instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR-II) solution for injection and Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (Accidental overdose, Wrong product administered, Product administered to patient of inappropriate age). No additional adverse events. The vaccine was reconstituted with sterile diluent (lot # and expiry date were not provided)). At the reporting time, the outcome of the events was unknown. The action taken with the suspect vaccines was not applicable.

Other medications

DILUENT MRK